Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
Rangering i aksjer #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Aksjekurs
$0.0005
Sist synkronisert: 2025-04-08
Markedsverdi
$118.05K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel QuantRx Biomedical Corporation (QTXB)

Kategori

EPS for QuantRx Biomedical Corporation (QTXB)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til QuantRx Biomedical Corporation er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for QuantRx Biomedical Corporation fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter